Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of 5-ALA HCl fluorescence-guided versus conventional white-light microsurgical resection in malignant glioma (WHO grade 3/4)
CTR20240446Phase 3Active
- Sponsor
- Zhaoke Pharmaceutical
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 5-aminolevulinic acid in malignant glioma, sponsored by Zhaoke Pharmaceutical. Started Apr 2025; status: active.
02
Drugs
5-aminolevulinic acid
03
Conditions
malignant glioma
Beyond the preview
Go deeper on CTR20240446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240446.